A coalition of more than 20 international partners has announced the Global One Health Diagnostic Access Compact during the G7 One Health Summit in Lyon, France, with Ceva Animal Health listed among the signatories.

The initiative is designed to accelerate access to diagnostics, support earlier pathogen detection and improve surveillance and response to existing and emerging health threats across human, animal and environmental health. According to the announcement published by Ceva, the Compact aims to strengthen global preparedness through science-based One Health approaches. 

The agreement comes at a time when health threats are becoming increasingly interconnected. Climate change can support the spread of disease vectors, animal-to-human transmission events are drawing greater attention, and antimicrobial resistance remains one of the most important global health challenges. In many regions, the announcement notes that basic capacity to identify bacteria and other pathogens is limited or absent, while health data across human, animal and environmental systems often remains fragmented. 

From The Animal Economics perspective, the Compact is important because diagnostics are not only a clinical tool; they are also an economic infrastructure. Better access to diagnostics can help reduce inappropriate treatment, support more responsible antimicrobial use, improve disease surveillance and strengthen decision-making across livestock, companion animal and public health systems.

The partners behind the Compact commit to four main areas: improving access to appropriate high-quality diagnostic tools, strengthening responsible use of diagnostics and antibiotics, investing in research and development for public health needs, and improving the value and integration of diagnostics into clinical, public health and animal health settings. 

For animal health companies, this type of collaboration reflects a broader shift in the sector. Disease prevention and treatment are increasingly linked with surveillance, data, diagnostics and cross-sector partnerships. In livestock production, earlier diagnosis can reduce losses and help protect food systems. In companion animal health, it can support more precise treatment decisions. At the public health level, it can contribute to faster detection of zoonotic and antimicrobial resistance risks.

The list of partners includes organizations from civil society, private companies, professional and scientific societies, foundations and global health initiatives. Alongside Ceva Animal Health, signatories include organizations such as bioMerieux, Roche Diagnostics, the American Society for Microbiology, the AMR Action Fund and others. 

For Ceva, participation in the Compact fits within a wider One Health positioning, where animal health is viewed as part of a broader system connecting people, animals and the environment. For the industry, the agreement highlights how diagnostics are becoming a strategic priority in global health preparedness, antimicrobial stewardship and future disease-response capacity.